Ospedale Fatebenefratelli di Roma Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2006
NCT00609401
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Medicina Oncologica - Ospedale Fatebenefratelli - Roma | Ospedale Fatebenefratelli di Roma, Oncologia

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 2)

Carcinoma, Renal Cell (Phase 2)

Neoplasm Metastasis (Phase 2)

Stomach Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 6